Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

DNA Damage can Stall the Cell Cycle

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

DNA Damage Can Stall the Cell Cycle

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Deciphering the Role of Cancer Stem Cells in Breast Cancer Brain Colonization Using a Novel Patient-Derived Model.

Advanced healthcare materials·2026

Same author

FAK signaling pathways are modulated by HSPB8 and BAG3 in breast cancer.

Cell communication and signaling : CCS·2026

Same author

SH3BP5L triggers the RAB11A-regulated integrin recycling network implicated in breast cancer metastasis.

The Journal of clinical investigation·2026

Same author

Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer.

Molecular diagnosis & therapy·2025

Same author

The CRL7<sup>FBXW8</sup> Complex Controls the Mammary Stem Cell Compartment through Regulation of NUMB Levels.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same author

Cancer cell stiffening via CoQ<sub>10</sub> and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer.

Nature communications·2024

Search research articles

Related Experiment Video

Updated: Jun 30, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

NUMB controls p53 tumour suppressor activity.

Ivan N Colaluca¹, Daniela Tosoni, Paolo Nuciforo

¹IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy.

|January 4, 2008

Summary

This summary is machine-generated.

NUMB protein loss in breast cancer activates the oncogene NOTCH and weakens the p53 tumor suppressor pathway. This dual effect promotes aggressive tumor phenotypes and poor prognosis, revealing a new tumor suppressor mechanism.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jun 30, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Area of Science:

Cell Biology
Cancer Biology
Molecular Oncology

Background:

NUMB is a known cell fate determinant regulating NOTCH signaling and possesses tumor suppressor roles in breast cancer.
The precise molecular mechanisms underlying NUMB's tumor suppressor functions remain incompletely understood.

Purpose of the Study:

To elucidate a novel function of human NUMB in regulating tumor protein p53 (TP53) stability and activity.
To investigate the consequences of NUMB loss in breast cancer, specifically its impact on p53 and NOTCH pathways.

Main Methods:

Investigated the interaction of NUMB with p53 and the E3 ubiquitin ligase HDM2 (MDM2) using biochemical assays.
Assessed the impact of NUMB expression levels on p53 protein levels, activity, and downstream phenotypes in primary breast tumor cells.
Analyzed NOTCH pathway activity and chemoresistance in the context of NUMB loss.

Main Results:

Discovered NUMB forms a tricomplex with p53 and HDM2, inhibiting p53 ubiquitination and degradation, thus stabilizing p53.
Demonstrated that loss of NUMB expression in breast cancer leads to decreased p53 levels and increased chemoresistance.
Showed that NUMB loss concurrently increases NOTCH receptor activity, contributing to an aggressive tumor phenotype and poor prognosis.

Conclusions:

NUMB acts as a crucial regulator of the p53 tumor suppressor pathway by stabilizing p53 protein.
Loss of NUMB in breast cancer simultaneously inactivates the p53 pathway and activates the oncogenic NOTCH pathway.
This dual inactivation/activation mechanism driven by NUMB loss establishes a novel tumor suppressor circuitry contributing to aggressive breast cancer progression.